Healthcare Infection Control Practices Advisory Committee (HICPAC); Designated Representative: Lisa Maragakis, MD, MPH
The Healthcare Infection Control Practices Advisory Committee (HICPAC) is a federal advisory committee appointed to provide guidance to DHHS and CDC regarding the practice of infection control and strategies for surveillance, prevention, and control of healthcare-associated infections, antimicrobial resistance and related events in the United States healthcare settings. HICPAC has nominated Dr. Lisa Maragakis to serve as their designated representative.
Lisa Maragakis serves as the Co-Chair of the Centers for Disease Control and Prevention's Healthcare Infection Control Practices Advisory Committee (HICPAC), a federal advisory committee that provides advice and guidance to HHS and CDC on infection control practices and strategies for the surveillance, prevention, and control of healthcare-associated infections (HAIs), antimicrobial resistance, and adverse events in United States healthcare settings. Dr. Maragakis is an associate professor of medicine and epidemiology at Johns Hopkins University School of Medicine and the Johns Hopkins Bloomberg School of Public Health. She is the Senior Director of Infection Prevention, at The Johns Hopkins Health System and the Hospital Epidemiologist for The Johns Hopkins Hospital. In these roles, she is responsible for the conceptualization, planning, implementation, and development of the Johns Hopkins Health System's infection control and prevention program.
Her research interests are the epidemiology, prevention and control of healthcare–acquired infections and antimicrobial-resistant gram-negative bacilli. Dr. Maragakis serves as the Executive Director of the Johns Hopkins Hospital Biocontainment Unit and as Incident Commander for the Johns Hopkins Medicine COVID-19 response. She also serves as the IDSA Co-Chair for the 2014 and 2020 Updates of the Compendium of Strategies to Prevent Healthcare-Associated Infections.
